Trial site
American Heart of Poland S.A.
- 14running trials
- 9closed trials
The trials here
What the 24 trials at this site are about, from their registry records.
- Conditions
- Heart failure9 trials
- Atrial fibrillation4 trials
- Chronic kidney disease4 trials
- Coronary artery disease3 trials
- Obesity3 trials
- High blood pressure2 trials
- Stroke2 trials
- Peripheral artery disease1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 314 trials
- Phase 29 trials
- Phase 41 trial
- Status
- Completed9 trials
- Active, not recruiting7 trials
- Recruiting6 trials
- Not yet recruiting1 trial
- Suspended1 trial
- Lead sponsor
- AstraZeneca4 trials
- Novo Nordisk A/S4 trials
- Amgen Inc.2 trials
- Bayer2 trials
- Acesion Pharma1 trial
- and 11 more
Running trials
Recruiting
Not yet recruiting
Recruiting
A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
Recruiting
Recruiting
Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Empagliflozin and dapagliflozin for improvement of outcome in patients with acute heart failure
Active, not recruiting
Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure3 recruiting
- Atrial fibrillation2 recruiting
- Obesity2 recruiting
- Peripheral artery disease1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026